Clinical Trial

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)

Study acronym: CeMoD-prime
Recruiting
View on ClinicalTrials.gov →
Summary
A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-09-16; most recent amendment 2025-12-15.
Status change: Not Yet Recruiting → Recruiting 2023-01-13
Trial Details
NCT Number NCT05547984
Lead Sponsor Aesculap AG
Conditions Coxarthrosis; Primary
Enrollment 100 participants
Start Date 2022-11-21
Primary Completion 2027-09 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2025-12-16